214 related articles for article (PubMed ID: 37619484)
1. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm.
Roshani M; Molavizadeh D; Sadeghi S; Jafari A; Dashti F; Mirazimi SMA; Ahmadi Asouri S; Rajabi A; Hamblin MR; Anoushirvani AA; Mirzaei H
Biomed Pharmacother; 2023 Oct; 166():115264. PubMed ID: 37619484
[TBL] [Abstract][Full Text] [Related]
2. Revisiting Inhibition Effects of miR-28 as a Metastasis Suppressor in Gastrointestinal Cancers.
Razi Soofiyani S; Minaei Beirami S; Hosseini K; Mohammadi Nasr M; Ranjbar M; Forouhandeh H; Tarhriz V; Sadeghi M
Microrna; 2023; 12(2):131-142. PubMed ID: 37073155
[TBL] [Abstract][Full Text] [Related]
3. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.
Jothimani G; Bhatiya M; Pathak S; Paul S; Banerjee A
Recent Adv Inflamm Allergy Drug Discov; 2022; 16(1):5-15. PubMed ID: 35670340
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers.
Sadri F; Hosseini SF; Aghayei A; Fereidouni M; Rezaei Z
DNA Cell Biol; 2022 Sep; 41(9):810-823. PubMed ID: 35914029
[TBL] [Abstract][Full Text] [Related]
5. Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.
Li C; Gao Y; Zhang K; Chen J; Han S; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 37(6):2143-59. PubMed ID: 26606597
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response.
Ashrafizadeh M; Mohan CD; Rangappa S; Zarrabi A; Hushmandi K; Kumar AP; Sethi G; Rangappa KS
Med Res Rev; 2023 Sep; 43(5):1263-1321. PubMed ID: 36951271
[TBL] [Abstract][Full Text] [Related]
8. miR-197: A novel biomarker for cancers.
Wang DD; Chen X; Yu DD; Yang SJ; Shen HY; Sha HH; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Oct; 591(2):313-9. PubMed ID: 27320730
[TBL] [Abstract][Full Text] [Related]
9. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
10.
Wang JY; Zhang Q; Wang DD; Yan W; Sha HH; Zhao JH; Yang SJ; Zhang HD; Hou JC; Xu HZ; He YJ; Hu JH; Zhong SL; Tang JH
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29217524
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
[TBL] [Abstract][Full Text] [Related]
14. Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications.
Tapeh BEG; Mosayyebi B; Mansoori B; Gravand ZA; Sarvnaz H; Mohammadi A
Anticancer Agents Med Chem; 2021; 21(17):2304-2314. PubMed ID: 33596811
[TBL] [Abstract][Full Text] [Related]
15. Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
Zhang H; Li M; Kaboli PJ; Ji H; Du F; Wu X; Zhao Y; Shen J; Wan L; Yi T; Wen Q; Li X; Cho CH; Li J; Xiao Z
Int J Biol Markers; 2021 Jun; 36(2):22-32. PubMed ID: 33788641
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-613: A novel tumor suppressor in human cancers.
Mei J; Xu R; Hao L; Zhang Y
Biomed Pharmacother; 2020 Mar; 123():109799. PubMed ID: 31877552
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target.
Ma Y; Cao X; Shi G; Shi T
Curr Pharm Des; 2021; 27(19):2264-2273. PubMed ID: 33121400
[TBL] [Abstract][Full Text] [Related]
18. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
19. Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.
Xu G; Yang Z; Sun Y; Dong H; Ma J
Discov Oncol; 2021 Sep; 12(1):33. PubMed ID: 35201458
[TBL] [Abstract][Full Text] [Related]
20. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
